Connection
Kevin Lillehei to Immunotherapy
This is a "connection" page, showing publications Kevin Lillehei has written about Immunotherapy.
|
|
Connection Strength |
|
|
|
|
|
0.655 |
|
|
|
-
Liu Y, Wang Q, Kleinschmidt-DeMasters BK, Franzusoff A, Ng KY, Lillehei KO. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors. J Neurooncol. 2007 Jan; 81(2):149-62.
Score: 0.213
-
Yang L, Ng KY, Lillehei KO. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma. Cancer Control. 2003 Mar-Apr; 10(2):138-47.
Score: 0.167
-
Liu Y, Ng K, Lillehei KO. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy. Neurosurg Focus. 2000 Dec 15; 9(6):e3.
Score: 0.144
-
Lillehei KO, Liu Y, Kong Q. Current perspectives in immunotherapy. Ann Thorac Surg. 1999 Sep; 68(3 Suppl):S28-33.
Score: 0.131